Preclinical Research
Geometric Determinants of Full-Thickness Wound Healing in Adult Male Yucatan Miniature Swine
Development of a Model of Dermal Inflammation and Irritation (Urticaria) in Miniature Swine
Dermal Toxicology Application Area Changes as Compared to a Theoretical Total Surface Area of Hanford Miniature Swine Over 18 Weeks
Acute Dermal Irritation Response in White Sinclair and Hanford Miniature Swine
Test Your Knowledge of PCR Applications
PCR testing continues to be in the spotlight as a reliable way of screening for COVID-19 and other viruses in patients. Its amplification process enables it to detect small portions of genetic material in these viruses. But PCR can be also used for a broad range of additional applications.
[NEW PODCAST] Microsampling: When Small Steps Lead to Big Outcomes
Microsampling: When Small Steps Lead to Big Outcomes
Join us as Dr. Donald Chace and Jeff Plomley discuss the many advantages of incorporating microsampling into your drug development program.
Altasciences is at the forefront of microsampling, leveraging innovative technology that allows for significantly reduced blood volumes to be taken from test subjects for analysis. Our experts have developed specialized workflows and methods to take full advantage of current microsampling technology at the preclinical, clinical, and bioanalytical levels, supporting the efficient advancement of your drug development program. Our services are fully customizable, available as stand-alone, or as part of a complete development program.
You may also be interested in the following:
- The Altascientist: Microsampling in Drug Development
- Webpage: Patient Centricity and the Evolving Role of Microsampling
- Webpage: Comprehensive Bioanalytical Services
- PDF: Altasciences' Proprietary Bioanalytical Assay List
Transforming the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, Altasciences offers a unique integrated approach to CRO and CDMO s
Case Study―Safety Assessment of Intravitreal Implants in Dutch Belted Rabbits
Reduce Your Drug Development Costs and Delays
Benefit from Partnering with a Single CRO/CDMO Partner―From Formulation to Preclinical to Clinical
The drug development journey often involves working with different CRO and CDMO partners. But there’s a simpler, more efficient solution!
Altasciences’ fully integrated, end-to-end offering means seamless transition from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This reduces complex handoffs, communication errors, and delays.
Discover how we support you through each phase of your drug development.
Related pages:
- Webpage: Formulation, Development, and Manufacturing Solutions
- Virtual Tour: Manufacturing Facility and Analytical Laboratories
- Webinar: Overcoming Challenges of Manufacturing in Clinical Trials
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Accelerate the Development of Your CNS-Active Drugs with Pharmacodynamic Measures
Accelerate the Development of Your CNS-Active Drugs with Pharmacodynamic Measures
Strategic design and targeted use of pharmacodynamic measures can greatly assist in evaluating the safety and potential efficacy of your new drug candidate in the early stages of clinical development.
In this on-demand webinar, our experts discuss how to include validated models of pain, anxiety, and other psychiatric conditions as part of a battery of tests for cognition and safety, to evaluate a drug’s potential for abuse or dependence, as well as its ability to enhance or impair performance.
You may also be interested in the following:
- The Altascientist: Considerations for Your CNS-active Drug Development Program
- Webinar — Assessing Cognition and Driving Ability in Clinical Pharmacology Studies
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programmes, to offer an integrated/synchronized approach to CRO and CDMO services.